| scholarly article | Q13442814 |
| P2093 | author name string | Jun Huang | |
| Yang Liu | |||
| Liang Chen | |||
| Xing Wang | |||
| Zhong-Liang Deng | |||
| Ke Wu | |||
| Bai-Cheng He | |||
| Guo-Wei Zuo | |||
| Ran-Xi Zhang | |||
| Ying-Zi Liu | |||
| Liang-Jun Yin | |||
| Jin-Yong Luo | |||
| Zi-Jun Meng | |||
| P2860 | cites work | Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells | Q40183990 |
| P433 | issue | 2 | |
| P304 | page(s) | 795-803 | |
| P577 | publication date | 2014-05-22 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling | |
| P478 | volume | 45 |
| Q59792061 | DLX3 Inhibits the Proliferation of Human Dental Pulp Cells Through Inactivation of Canonical Wnt/β-Catenin Signaling Pathway |
| Q26796359 | Molecular Insight in the Multifunctional Effects of Oridonin |
| Q56556302 | Oridonin inhibits growth and induces apoptosis of human neurocytoma cells via the Wnt/β-catenin pathway |
| Q42089338 | Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway |
| Q41343608 | Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors |
| Q37745377 | Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs |
| Q46735582 | Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways. |
| Q34663910 | Wnt/β-catenin pathway in bone cancers |
Search more.